Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
09/2012
09/04/2012US8257745 Use of synthetic inorganic nanoparticles as carriers for ophthalmic and otic drugs
09/04/2012CA2432971C Polypeptides
09/04/2012CA2351982C Selection and uses of lactic acid bacteria strains modulating non-specific immunity
08/2012
08/30/2012WO2012116280A2 Formulations useful for spray drying vaccines
08/30/2012WO2012116225A2 Muc1 based glycolipopeptide vaccine with adjuvant
08/30/2012WO2012115715A2 Compositions with enhanced immunogenicity and/or reduced reactogenicity and methods of use
08/30/2012WO2012115209A1 Soluble epoxide hydrolase inhibitor
08/30/2012WO2012114268A1 Benzamide derivatives as p2x7 receptor antagonists
08/30/2012WO2012113813A1 Antibodies against human il33r and uses thereof
08/30/2012WO2012092157A3 Nutritional formulations including human milk oligosaccharides and long chain polyunsaturated polyunsaturated fatty acids and uses thereof
08/30/2012WO2012091081A8 Interferon production-inducing agent containing lactic acid bacteria
08/30/2012US20120220921 Immunologically modified carbon nanotubes for cancer treatment
08/30/2012US20120220651 Desferrioxamine-metal complexes for the treatment of immune-related disorders
08/30/2012US20120220631 USE OF 5H-THIOENO(3,4-c)PYRROLE-4,6-DIONE DERIVATIVES AS TUMOR NECROSIS FACTOR INHIBITOR
08/30/2012US20120220611 1,3-benzoxazolyl derivatives as kinase inhibitors
08/30/2012US20120220606 New capped pyrazinoylguanidine sodium channel blockers
08/30/2012US20120220592 2-phenylethylamino derivatives as calcium and/or sodium channel modulators
08/30/2012US20120220590 Novel compounds as modulators of glucocorticoid receptors
08/30/2012US20120220587 Pyridinylimidazolone derivatives for the inhibition of pi3 kinases
08/30/2012US20120220586 Heterocyclic compounds and their uses
08/30/2012US20120220585 Heterocyclic compounds and their uses
08/30/2012US20120220582 Imidazopyrazine syk inhibitors
08/30/2012US20120220575 N-substituted oxazinopteridines and oxazinopteridinones
08/30/2012US20120220573 Benzodiazepine Bromodomain Inhibitor
08/30/2012US20120220571 Hiv integrase inhibitors
08/30/2012US20120220568 Histamine-3 Receptor Antagonists
08/30/2012US20120220561 Oxadiazole inhibitors of leukotriene production
08/30/2012US20120220560 Steroid tetrol solid state forms
08/30/2012US20120219624 Process for preparing products comprising stabilised actives and compositions comprising same
08/30/2012US20120219617 MUC1 Based Glycolipopeptide Vaccine with Adjuvant
08/30/2012US20120219614 Methods and compositions for preventing a condition
08/30/2012US20120219605 Adjuvanted nanoparticulate influenza vaccine
08/30/2012US20120219597 Pharmaceutical formulations for indibulin
08/30/2012US20120219596 Injectable formulation for treatment and protection of patients having an inflammatory reaction or an ischemia-reperfusion event
08/30/2012US20120219593 Indolylmaleimide derivatives processes for their production and pharmaceutical compositions
08/30/2012US20120219592 Use of B-Aminoalcohols in the Treatment of Inflammatory Disorders and Pain
08/30/2012US20120219591 Use of vectors expressing intracellular polynucleotide binding proteins as adjuvants
08/30/2012US20120219590 Formulations useful for spray drying vaccines
08/30/2012US20120219588 Methods for purification of viruses
08/30/2012US20120219587 Process for producing influenza vaccine
08/30/2012US20120219586 Adjuvanted vaccine formulations
08/30/2012US20120219584 Protection against pandemic and seasonal strains of influenza
08/30/2012US20120219583 Nucleic acid sequences encoding expandable hiv mosaic proteins
08/30/2012US20120219580 Highly pathogenic avian influenza virus protein vaccine derived from transgenic plant, and preparing method thereof
08/30/2012US20120219579 Virus like particles comprising target proteins fused to plant viral coat proteins
08/30/2012US20120219578 Neisserial antigenic peptides
08/30/2012US20120219577 Hiv-1 clade a consensus sequences, antigens, and transgenes
08/30/2012US20120219576 Lassa virus-like particles and methods of production thereof
08/30/2012US20120219575 Peptide Sequences and Compositions
08/30/2012US20120219574 Antigen surrogates in autoimmune disease
08/30/2012US20120219573 Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic acids
08/30/2012US20120219572 Spheroidal Aggregates of Mesenchymal Stem Cells
08/30/2012US20120219571 Combination motif immune stimulatory oligonucleotides with improved activity
08/30/2012US20120219565 Engineered anti-tslp antibody
08/30/2012US20120219564 Human Antibodies That Bind Human TNFalpha
08/30/2012US20120219559 Methods of modulating immune function
08/30/2012US20120219555 Auto-antibody markers of autoimmune disease
08/30/2012US20120219554 Extracellular yaluronidase from streptomyces koganeiensis
08/30/2012US20120219553 Use of a cd258 binding pharmaceutical substrance for making a pharmaceutical composition with dose-dependent effect
08/30/2012US20120219547 Humanized Anti-TNFalpha Antibodies
08/30/2012US20120219546 Methods for treating conditions mediated by the inflammatory cytokine cascade using gapdh inhibitors
08/30/2012US20120219545 Materials and methods for diagnosing and treating shellfish allergy
08/30/2012US20120219540 Compositions and methods for modulating immune responses
08/30/2012US20120219504 Complex of a protein comprising zinc oxide-binding peptides and zinc oxide nanoparticles, and use thereof
08/30/2012US20120219503 Humanized antibodies specific for amino acid sequence rgd of an extracellular matrix protein and the uses thereof
08/30/2012US20120219501 Biomarker en2 for gynaecological cancer
08/30/2012US20120219495 Novel tetraaza macrocyclic compound, preparation method thereof and use thereof
08/30/2012CA2828248A1 Formulations useful for spray drying vaccines
08/30/2012CA2825972A1 Muc1 based glycolipopeptide vaccine with adjuvant
08/30/2012CA2824500A1 Antibodies against human il33r and uses thereof
08/30/2012CA2824415A1 Benzamide derivatives as p2x7 receptor antagonists
08/29/2012EP2491949A1 Peptides derived from the major allergen of ragweed (ambrosia artemisiifolia) and uses thereof
08/29/2012EP2491948A1 Peptides derived from the major allergen of ragweed (ambrosia artemisiifolia) and uses thereof
08/29/2012EP2491940A2 Method for inducing cytotoxic T-cells, cytotoxic T-cell inducer, and pharmaceutical composition and vaccine employing same
08/29/2012EP2491039A1 Heterocyclyl pyrazolopyrimidine analogues as jak inhibitors
08/29/2012EP2491036A2 Pyrazolopyrimidine derivatives
08/29/2012EP2491023A2 Coumarin compounds as receptor modulators with therapeutic utility
08/29/2012EP2490678A1 Coated capsules and tablets of a fatty acid oil mixture
08/29/2012CN1997395B Drug having regulatory cell ligand contained in liposome
08/29/2012CN1976950B Anti-CD38 human antibodies and uses therefor.
08/29/2012CN102652020A Combination preparations comprising exosomes and corticosteroid
08/29/2012CN102648927A Production technology of petasites lactone compound
08/29/2012CN102648924A Anti-tumor and immunity-enhancing activity of Fomitopsis pinicola Karst fermentation product
08/29/2012CN102648918A New application of fructose diphosphate
08/29/2012CN102648910A Immune enhancement composition and kit and use thereof
08/29/2012CN102178913B Skin care pill for treating cold sensitive disease and preparation method thereof
08/29/2012CN102139015B Medicinal liquor capable of balancing yin and yang and improving immunity and preparation thereof
08/29/2012CN102058731B Preparation of chaste tree twig leaf and fruit extract and anti-inflammatory medical application thereof
08/29/2012CN102028775B Medicament or health-care food for preventing and treating chloasma and regulating immunologic function
08/29/2012CN101574391B Prevention and treatment of diseases induced by microcirculation disturbance with compatible combination of total salvianolic acid and panax notoginoside
08/29/2012CN101331229B Immunostimulatory oligoribonucleotides
08/29/2012CN101257919B Antigen-and-drug vehicle which enables the changeover from the selective production of lgA antibody to the production of both of lgA and lgG antibodies, and transnasal/transmucosal vaccine using the vehicle
08/29/2012CN101146529B Novel thiophene derivatives as sphingosine-1-phosphate-1 receptor agonists
08/29/2012CN101028519B Pharmaceutical composition for treating immune diseases
08/28/2012US8252929 8-carboxamido-2,6-methano-3-benzazocines
08/28/2012US8252909 Synthetic C-glycolipid and its use for treating cancer, infectious diseases, and autoimmune diseases
08/28/2012US8252818 Nicotinamide derivatives useful as P38 inhibitors
08/28/2012US8252797 Heterocyclic compounds as adenosine receptor antagonist
08/28/2012US8252322 Delivery system with increased bioavailability
08/28/2012CA2395632C A bimer or an oligomer of a dimer, trimer, quadromer or pentamer of recombinant fusion proteins
1 ... 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 ... 1172